Trends in Use of Prescribed Opioids in Incident and Prevalent Patients With Ulcerative Colitis: A Nationwide Study in Sweden
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izaf278 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Mehdi Osooli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Analgesics, Opioid, Drug Prescriptions, Pain Management. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Regional Agreement on Medical Training and Clinical Research between Stockholm County Council, Karolinska Institutet.
Abstract (Originalsprache)
Background and Aims Opioids are not optimal for managing pain among patients with ulcerative colitis (UC), but the use of opiods in nationwide UC populations remains unexplored. We aimed to describe dispensed opioid use around UC diagnosis and annual trends among patients with prevalent UC.
Methods
We performed a nationwide population-based cohort study of adults with an incident (2008-2020) or a prevalent (2006-2022) UC diagnosis and matched reference individuals from the general population. We obtained data on opioid dispensations and estimated the prevalence of having ≥1 dispensation per six-month period from two years before until five years following a first UC diagnosis. We also estimated annual opioid use among participants with a prevalent UC diagnosis and their matched reference individuals.
Results
Overall, 66 929 adults with UC (including 25 417 patients with an incident diagnosis) and 641 609 matched reference individuals were included. Compared to reference individuals, patients with UC had a 1.3-fold higher prevalence of opioid use (6.4% vs 4.9%) two years before diagnosis, which peaked during the year of diagnosis (11.0%) and stabilized at a 1.7-fold higher use three to five years after diagnosis. Between 2006 and 2022 the annual prevalence of opioid use decreased by 15.0% in patients with UC and by 11.0% in reference individuals.
Conclusion
In this nationwide register-based study, adults with UC had higher prescribed opioid use within two years before and up to five years after first UC diagnosis compared with reference individuals. However, adults with prevalent UC (and reference individuals) had a declining temporal opioid use trend during 2006-2022.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska University Hospital, Stockholm, Sweden.
- Department of Pelvic Cancer, Unit of IBD-surgery, Karolinska University Hospital, Stockholm, Sweden.
- Karolinska University Hospital, Centre for Digestive Health, Department of Gastroenterology Dermatovenereology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
- Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Mehdi Osooli, Charlotte R H Hedin, Jonas F Ludvigsson
Förderung
- Swedish Research Council
- Regional Agreement on Medical Training and Clinical Research between Stockholm County Council
- Karolinska Institutet
- Karolinska Institutet Foundation
- Regional Agreement on Medical Training and Clinical Research between Stockholm County Council and Karolinska Institutet
Zitieren
APA
Osooli, M., Voghera, S., Bruze, G., Nordenvall, C., Hedin, C. R. H., Everhov, Å. H., Myrelid, P., Ludvigsson, J. F., Olén, O., & SWIBREG Study Group§ (2025). Trends in Use of Prescribed Opioids in Incident and Prevalent Patients With Ulcerative Colitis: A Nationwide Study in Sweden. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf278
Vancouver
Osooli M, Voghera S, Bruze G, Nordenvall C, Hedin CRH, Everhov ÅH, et al. Trends in Use of Prescribed Opioids in Incident and Prevalent Patients With Ulcerative Colitis: A Nationwide Study in Sweden. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izaf278
BibTeX
@article{Osooli2025,
author = {Osooli, Mehdi and Voghera, Siri and Bruze, Gustaf and Nordenvall, Caroline and Hedin, Charlotte R H and Everhov, Åsa H and Myrelid, Pär and Ludvigsson, Jonas F and Olén, Ola and SWIBREG Study Group§, SWIBREG Study Group§},
title = {Trends in Use of Prescribed Opioids in Incident and Prevalent Patients With Ulcerative Colitis: A Nationwide Study in Sweden},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izaf278}
}
EUVIMED